Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma
Author(s) -
Anke van Erp,
Melissa H.S. Hillebrandt-Roeffen,
Niek van Bree,
Tim A. Plüm,
Uta Flucke,
Ingrid M.E. Desar,
Emmy D.G. Fleuren,
Winette T.A. van der Graaf,
Yvonne M.H. VersleijenJonkers
Publication year - 2022
Publication title -
sarcoma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.781
H-Index - 41
eISSN - 1369-1643
pISSN - 1357-714X
DOI - 10.1155/2022/3089424
Subject(s) - dasatinib , rhabdomyosarcoma , cancer research , proto oncogene tyrosine protein kinase src , sarcoma , viability assay , embryonal rhabdomyosarcoma , medicine , cell culture , pathology , biology , receptor , imatinib , myeloid leukemia , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom